Accelerating preclinical development toward IND submission in H1 next year, positioning ABN202 as a potential game changer in oncologySEOUL, South Korea--(BUSINESS WIRE)--#AACR2026--ABION (KOSDAQ, ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its first quarter 2026 financial results on Monday, May 4, 2026, after the financial markets close. The company will host a conference ...

CAMBRIDGE, MA / ACCESS Newswire / April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present late-breaking oral presentations on revaccination data for both mRNA-1010, ...

Fluor Corporation (NYSE: FLR) announced today that it has entered into a contract with X-energy to support the company’s ...

NEW YORK CITY, NY / ACCESS Newswire / April 6, 2026 / Emerging Growth Research today announced the release of its Quarterly Update Report on SBC Medical Group Holdings, Inc. (Nasdaq:SBC), reiterating ...

LEXINGTON, KY / ACCESS Newswire / April 6, 2026 / NX Development Corp (NXDC) is pleased to announce that after successfully ...

Wilson Encourages Investors Who Suffered Losses In Ultragenyx To Contact Him Directly To Discuss Their OptionsIf you ...

Total Knee Replacement Market OverviewThe global total knee replacement (TKR) market is projected to witness steady growth over the next five years with an estimated growth rate of around 5%. The ...

Poultry Medicine Market OverviewThe global poultry medicine market is expected to experience steady growth over the next five years, with an anticipated growth rate of approximately 7%. The expansion ...

Company to showcase expansion opportunity for EVO756 (MRGPRX2 Antagonist) into third indication of migraine prophylaxis; ...

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for ...

The global pulse oximeter market is expected to expand at a compound annual growth rate (CAGR) of approximately 7% over the ...